Immunic, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Immunic, Inc. (IMUX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 4.69 million shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2019-04-10
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-03-31 was 4.69M shares, a 39708.51% increase year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-12-31 was 1.27M shares, a 13329.84% increase year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-09-30 was 1.40M shares, a 6099.30% increase year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-06-30 was 32.15K shares, a 72.36% decline year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2018 was 2.72M shares, a 1597.51% increase from fiscal 2017.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2017 was 159.96K shares, a 120.18% increase from fiscal 2016.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2016 was 72.65K shares, a 66.81% decline from fiscal 2015.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2015 was 218.88K shares, a 203.31% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2019-03-31 | 4.69M shares 10-Q · filed 2019-04-10 | 5.96M shares derived: sum of 2 quarters · filed 2019-04-10 | 7.36M shares derived: sum of 3 quarters · filed 2019-04-10 | 7.39M shares derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-12-31 | 1.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | 2.67M shares derived: sum of 2 quarters · filed 2019-03-04 | 2.70M shares derived: sum of 3 quarters · filed 2019-03-04 | 2.72M shares 10-K · filed 2019-03-04 |
| 2018-09-30 | 1.40M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 1.43M shares derived: sum of 2 quarters · filed 2018-11-08 | 1.44M shares 10-Q · filed 2018-11-08 | 1.45M shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 32.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 43.93K shares 10-Q · filed 2018-08-07 | 53.39K shares derived: sum of 3 quarters · filed 2018-08-07 | 75.98K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 11.78K shares 10-Q · filed 2018-05-08 | 21.24K shares derived: sum of 2 quarters · filed 2018-05-08 | 43.83K shares derived: sum of 3 quarters · filed 2018-05-08 | 160.16K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 9.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 32.05K shares derived: sum of 2 quarters · filed 2018-03-13 | 148.38K shares derived: sum of 3 quarters · filed 2018-03-13 | 159.96K shares 10-K · filed 2018-03-13 |
| 2017-09-30 | 22.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | 138.91K shares derived: sum of 2 quarters · filed 2017-10-25 | 150.49K shares 10-Q · filed 2017-10-25 | 175.46K shares derived: sum of 4 quarters · filed 2017-10-25 |
| 2017-06-30 | 116.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 127.90K shares 10-Q · filed 2017-08-03 | 152.87K shares derived: sum of 3 quarters · filed 2017-08-03 | 176.97K shares derived: sum of 4 quarters · filed 2017-08-03 |
| 2017-03-31 | 11.58K shares 10-Q · filed 2017-05-09 | 36.55K shares derived: sum of 2 quarters · filed 2017-05-09 | 60.64K shares derived: sum of 3 quarters · filed 2017-05-09 | 79.33K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 24.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | 49.06K shares derived: sum of 2 quarters · filed 2017-03-07 | 67.75K shares derived: sum of 3 quarters · filed 2017-03-07 | 72.65K shares 10-K · filed 2017-03-07 |
| 2016-09-30 | 24.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 42.78K shares derived: sum of 2 quarters · filed 2016-11-03 | 47.68K shares 10-Q · filed 2016-11-03 | 108.36K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 18.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 23.58K shares 10-Q · filed 2016-08-02 | 84.27K shares derived: sum of 3 quarters · filed 2016-08-02 | 199.13K shares derived: sum of 4 quarters · filed 2016-08-02 |
| 2016-03-31 | 4.90K shares 10-Q · filed 2016-05-09 | 65.58K shares derived: sum of 2 quarters · filed 2016-05-09 | 180.44K shares derived: sum of 3 quarters · filed 2016-05-09 | 209.98K shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 60.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | 175.55K shares derived: sum of 2 quarters · filed 2016-03-08 | 205.08K shares derived: sum of 3 quarters · filed 2016-03-08 | 218.88K shares 10-K · filed 2016-03-08 |
| 2015-09-30 | 114.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 144.40K shares derived: sum of 2 quarters · filed 2015-11-05 | 158.20K shares 10-Q · filed 2015-11-05 | 184.40K shares derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | 29.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 43.33K shares 10-Q · filed 2015-08-06 | 69.53K shares derived: sum of 3 quarters · filed 2015-08-06 | 69.53K shares derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | 13.80K shares 10-Q · filed 2015-05-12 | 40.00K shares derived: sum of 2 quarters · filed 2015-05-12 | 40.00K shares derived: sum of 3 quarters · filed 2015-05-12 | 69.30K shares derived: sum of 4 quarters · filed 2015-05-12 |
| 2014-12-31 | 26.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20 | 26.20K shares derived: sum of 2 quarters · filed 2015-03-20 | 55.50K shares derived: sum of 3 quarters · filed 2015-03-20 | 72.16K shares 10-K · filed 2015-03-20 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 29.30K shares derived: sum of 2 quarters · filed 2014-11-13 | 45.97K shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 29.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 45.97K shares 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | 16.66K shares 10-Q · filed 2014-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |